The slip
PARKINSON RECEIPTno. 6831
22 Oct 2026, 21:30 UTCdopamine neurons, braak
predictionHERPUD1 in dopamine neurons tracks Braak Lewy-body stage
registeredcfeb8ae3176289c1
discovery-0.46 p=0.214 n=9
replication+0.15 p=0.697 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.46, p 0.214)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT5f4dee023856ee5fb5468498…
follows 6f9690e5b05b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6831: HERPUD1 in dopamine neurons, braak
- power
- full sample -0.22 (p 0.374, n 18), 95% CI -0.62 to +0.27. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.30 (p 0.221, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.35 (p 0.150, n 18). could be the mix.
- skeptic
- leave-one-out range -0.33 to -0.10, sign flips 0; without severely affected donors -0.22 (p 0.374, n 18). fragile.
- cell type
- strongest in oligodendrocytes: +0.65 (p 0.0036, n 18) vs -0.22 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for HERPUD1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up HERPUD1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.43 p 0.131 (needs p < 3.0e-4)